D&O Diary readers are aware of a growing trend over the past year: an increasing number of securities class actions arising from alleged market manipulation involving low-float public companies. These cases, ranging from pump-and-dump and spoofing schemes to stock promotion claims, now also include a lawsuit filed this week against Megan Holdings Limited (Megan), whose share price allegedly surged more than 400% in one month before plunging over 93% in a single trading day. The company, headquartered in Malaysia, develops, constructs, and maintains aquaculture farms and related infrastructure.
A copy of the lawsuit can be found here.
The Complaint
On July 7, 2026, investors filed a securities class action in the Southern District of New York against Megan, certain officers, its former auditor, and its IPO underwriter, alleging violations of the Securities Act of 1933 and the Securities Exchange Act of 1934. The complaint alleges that after Megan’s September 2025 $5 million IPO, its share price rose more than 400%—from about $1.23 to an intraday high of $5.18 between February 25 and March 25, 2026—despite no material company-specific news, before collapsing 93.4% to $0.28 on March 26, 2026.
According to the complaint, the surge resulted from a coordinated pump-and-dump scheme promoted through WhatsApp groups, online forums, and social media, where individuals posing as financial advisers allegedly used false identities and misleading materials to tout Megan shares. Plaintiffs allege the resulting artificial demand allowed conspirators to sell at inflated prices before the stock collapsed.
The suit also seeks to hold Megan, its executives, auditor, and underwriter liable for allegedly failing to disclose the promotion scheme, the risk of market manipulation, material weaknesses in internal controls, and the underwriter’s involvement in other low-float IPOs that experienced similar volatility. The complaint further alleges that Megan’s small public float made the stock particularly vulnerable to manipulation and argues that recent regulatory scrutiny of low-float issuers made these risks foreseeable.
Discussion
This lawsuit fits squarely within the market-manipulation trend, particularly alleged pump-and-dump schemes, that the D&O Diary has been closely tracking. Unlike traditional securities suits centered on accounting issues or operational setbacks, these cases arise from extraordinary trading activity that securities lawsuit plaintiffs attribute to market manipulation. Whether involving alleged pump-and-dump schemes, stock promotion campaigns, or, as in the Genius Group case, alleged spoofing activity, the common thread is shareholder plaintiffs’ effort to convert alleged market misconduct into federal securities law claims.
The Megan complaint closely resembles several of the low-float IPO cases previously discussed by the D&O Diary, including lawsuits against Charming Medical Limited, PomDoctor, Ltd., China Liberal Education Holdings Ltd. (“CLEU SCA”), and Picard Medical, Inc.. As in those cases, plaintiffs point to a small public float, rapid share-price appreciation unsupported by company-specific developments, heavy trading volume, aggressive promotion directed at retail investors, and a subsequent price collapse. The allegations focus less on the company’s business performance than on whether the company and offering participants failed to disclose circumstances that allegedly left the stock vulnerable to manipulation.
The litigation against Megan highlights another recurring feature of the recent low-float pump-and-dump cases: plaintiffs’ efforts to expand liability beyond the issuer and its executives. As in the Charming Medical lawsuit, shareholders in the new Megan Holdings suit have named the company’s auditor and IPO underwriter as defendants, alleging that they knew or should have known of risks associated with the offering and failed to ensure adequate disclosures. Rather than targeting only the alleged promoters or market manipulators, these suits seek to hold offering participants and other gatekeepers liable for purported disclosure failures relating to the issuer’s vulnerability to manipulation. The Megan complaint reflects this same evolving litigation strategy, which increasingly casts underwriters, auditors, and other advisers as potential defendants alongside the company and its management.
This trend involving alleged pump-and-dump schemes and other forms of market manipulation targeting low-float issuers, particularly foreign-based companies that recently completed U.S. IPOs, may gain further momentum as regulators intensify their focus on low-float and cross-border manipulation risks. The SEC’s 2025 formation of a Cross-Border Task Force specifically targeting foreign-based market manipulation schemes, coupled with Nasdaq’s efforts to tighten listing requirements for issuers viewed as particularly vulnerable to manipulation, suggests that these issues will remain a significant area of regulatory and litigation scrutiny.
Whether these theories ultimately gain traction in the courts remains uncertain. Many of these cases test the outer boundaries of the federal securities laws by seeking to transform alleged misconduct by third-party traders, promoters, and social-media actors into actionable disclosure claims against issuers and their advisers. Nevertheless, the proliferation of pump-and-dump, spoofing, and other manipulation-based securities suits suggests that market-manipulation litigation has become a distinct and growing category of securities class actions. With regulators continuing to focus on low-float issuers and cross-border promotion schemes, plaintiffs seem likely to continue pursuing these claims, making this a trend that D&O underwriters may want to monitor closely.